MIRA INFORM REPORT

 

 

Report Date :

06.05.2014

 

IDENTIFICATION DETAILS

 

Name :

QATAR INFUSIONS FACTORY WLL

 

 

Registered Office :

Building No. 51,            Street No. 29, Zone No. 81, New Industrial Area, P O Box 41119, Doha

 

 

Country :

Qatar 

 

 

Date of Incorporation :

30.03.2006

 

 

Com. Reg. No.:

29226/3

 

 

Legal Form :

With Limited Liability

 

 

Line of Business :

manufacturer of infusion drugs.

 

 

No of Employees :

350 (approximately)

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

 

 

Payment Behaviour :

No Complaints

 

 

Litigation :

Clear

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – March 31, 2014

 

Country Name

Previous Rating

(31.12.2013)

Current Rating

(31.03.2014)

Qatar

A2

A2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low Risk

 

A2

Moderate Low Risk

 

B1

Moderate Risk

 

B2

Moderate High Risk

 

C1

High Risk

C2

Very High Risk

 

D

 

Qatar ECONOMIC OVERVIEW

 

Qatar has prospered in the last several years with continued high real GDP growth. Throughout the financial crisis Qatari authorities sought to protect the local banking sector, with direct investments into domestic banks. GDP is driven largely by changes in oil prices and by investment in the energy sector. Economic policy is focused on developing Qatar's nonassociated natural gas reserves and increasing private and foreign investment in non-energy sectors, but oil and gas still account for more than 50% of GDP, roughly 85% of export earnings, and 50% of government revenues. Oil and gas have made Qatar the world's highest per-capita income country and the country with the lowest unemployment. Proved oil reserves in excess of 25 billion barrels should enable continued output at current levels for about 57 years. Qatar's proved reserves of natural gas exceed 25 trillion cubic meters, about 13% of the world total and third largest in the world. Qatar's successful 2022 World Cup bid is accelerating large-scale infrastructure projects such as Qatar's metro system, light rail system, the construction of a new port, roads, stadiums and related sporting infrastructure. The new Hamad International Airport is expected to open in mid-2014 with an annual passenger capacity of 24 million on initial opening and 50 million when complete.

 

Source : CIA

 

SUMMARY

 

Company Name                                    : QATAR INFUSIONS FACTORY WLL

Also Known As                                     : QATAR PHARMA

Country of Origin                                   : Qatar

Legal Form                                           : With Limited Liability - WLL

Registration Date                                  : 30th March 2006

Commercial Registration Number           : 29226/3

Chamber Membership Number               : 9114/1

Issued Capital                                       : QR 1,000,000

Paid up Capital                                     : QR 1,000,000

Total Workforce                         : 350

Activities                                               : Manufacturers of infusion drugs

Financial Condition                                : Undetermined

Payments                                             : Nothing detrimental uncovered

Person Interviewed                                : Ahmed Hamdy, Accountant

 

 

 

COMPANY NAME

 

QATAR INFUSIONS FACTORY WLL

 

 

ALSO KNOWN AS

 

QATAR PHARMA

 

 

company ADDRESS

 

Registered & Physical Address

Building                        : Building No. 51

Street               : Street No. 29

Area                 : Zone No. 81, New Industrial Area

PO Box            : 41119

Town                : Doha

Country : Qatar

 

Telephone         : (974) 44114242

Facsimile          : (974) 44114448

Mobile              : (974) 55509400

Email                : qatarpharma@qatar.net.qa

 

Please note that subject’s previous address was, Building No. 51, Street No. 81, Doha.

 

Premises

Subject operates from a large suite of offices and a factory that are rented and located in the Industrial Area of Doha.

 

 

KEY PRINCIPALS

 

     Name                                                                                               Position

 

·       Dr Ahmed Mohamed Hussain Al Sulaiti                                              Managing Director

 

·       Tamim Ahmed Mohamed Hussain Al Sulaiti                                        Director

 

·       Ali Ahmed Mohamed Hussain Al Sulaiti                                              Director

 

·       Dr Abdul Halim Jaffar                                                                       General Manager

 

·       Mohamed Antar                                                                                Finance Manager

 

·       Ahmed Hamdy                                                                                 Accountant

 

·       Yasser Qutub                                                                                   Commercial Manager

    

 

LEGAL FORM & OWNERS

 

Date of Establishment  : 30th March 2006 (Production began in 2011)

 

Legal Form                  : With Limited Liability - WLL

 

Commercial Reg. No.   : 29226/3

 

Chamber Member No.  : 9114/1

 

Issued Capital              : QR 1,000,000

 

Paid up Capital            : QR 1,000,000

 

Name of Shareholder (s)

·       Dr Ahmed Mohamed Hussain Al Sulaiti

·       Tamim Ahmed Mohamed Hussain Al Sulaiti

·       Ali Ahmed Mohamed Hussain Al Sulaiti

 

 

AFFILIATED COMPANIES

 

·       Al Sulaiti Holding

PO Box: 4453

Doha

Tel: (974) 44834999

Fax: (974) 44832823

 

 

OPERATIONS

 

Activities: Engaged in the manufacture of infusion drugs.

 

Subject is the first intravenous (sterile, pyrogenfree) infusion, haemodialysis and topical drug manufacturing facility in Qatar. Production capacity per year is 26,000,000 polypropylene bags, each with two ports, bags are of different sizes (50 ml, 100ml, 250ml, 500ml, 1000ml & 2000ml), 20,200,000 polyethylene, capped bottle 500ml and 5,000,000 jerry can size of 5 litres.

 

Import Countries: Europe and the Far East.

 

Subject has a workforce of approximately 350 employees.

 

 

FINANCIAL DATA

 

Companies registered in Qatar are not legally required to make their accounts public and no financial information was released by the company or submitted by outside sources.

 

 

BANKERS

 

·       HSBC Bank Middle East

Abdulla Bin Jassim Street

PO Box: 57

Doha

Tel: (974) 44423124

Fax: (974) 44416353

 

 

PAYMENT HISTORY

 

No complaints regarding subject’s payments have been reported.

 

 

GENERAL COMMENTS

 

During the course of this investigation nothing detrimental was uncovered regarding subject’s operating history or the manner in which payments are fulfilled. As such the company is considered to be a fair trade risk.

FOREIGN EXCHANGE RATES

 

Currency
Unit

Indian Rupees

US Dollar

1

Rs.60.05

UK Pound

1

Rs.101.32

Euro

1

Rs.83.34

 

 

INFORMATION DETAILS

 

Analysis Done by :

DIV

 

 

Report Prepared by :

MNL

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

Credit not recommended

--

NB

                                       New Business

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.